Le Lézard
Classified in: Health
Subjects: PDT, WOM

Georgia Launches Intelligent Technology to Improve Breast Exam Accuracy


GAINESVILLE, Fla., Oct. 17, 2018 /PRNewswire/ -- Women in Georgia will benefit from the breast exam training program developed by MammaCare? scientists with the support of the National Science Foundation. The team of scientists identified the specific breast exam skills required for early detection of small suspicious tumors while reducing false positives. They produced a hands-on, computer-guided simulator technology that validates the performance of these critical skills. In cooperation with the Georgia Department of Public Health Breast and Cervical Cancer Program (BCCP), the MammaCare system will train nurses in each of Georgia's 159 counties. The training technology is in use by the Women Veterans Health Program and by US colleges of nursing and medicine. Georgia's DPH is the first BCCP to deploy the training system statewide.

Although nurses and physicians routinely examine women's breasts for suspicious lesions or tumors, performance and results vary widely. Mary Ann Mehn, Ph.D., MammaCare's Director of Education, said that Georgia DPH staff public health nurses are now being trained and certified to deploy the system throughout Georgia's BCCP. Mark Kane Goldstein, Ph.D., MammaCare Senior Scientist explained: "The MammaCare Clinical Breast Exam Simulator-Trainer standardizes critical performance skills with a series of "intelligent" breast models that measure exam accuracy and provide corrective feedback in real time." "If performance on any one of the breast exam modules does not meet built-in standards of sensitivity, specificity, and thoroughness, the program requires the user to repeat the module before moving on to the next one," Goldstein added.

MammaCare, the recognized standard for clinical and personal breast exams, began in 1974 as a National Cancer Institute project to determine the smallest palpable breast tumor that is reliably detectable by hand. MammaCare training technology and certification courses are available at http://mammacare.org.

Contact

Mary Ann Mehn, Ph.D.,

[email protected]

Mark Kane Goldstein, Ph.D.

[email protected]

Cell: 352.256.4573

Office: 352.375.0607

Related Links

The MammaCare Foundation Website

Related Video

https://vimeo.com/250519953

SOURCE The MammaCare Foundation


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: